S&N diversifies with $1.7bn ArthroCare buy, but is it a sure bet?
This article was originally published in Clinica
Executive Summary
As previously predicted by Clinica, Smith & Nephew has made a $1.7bn swoop for ArthroCare, strengthening its sports medicine business and continuing its diversification efforts. Last month, Austin, Texas-based ArthroCare paid $30m to resolve a US criminal investigation that has been going on since 2008 regarding alleged fraud, making it an attractive acquisition target.